Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high- fat meal

JAMA

Volumn 278, Issue 20, 1997, Pages 1682-1686

  Plotnick, Gary D ^a,b   Corretti, Mary C ^a   Vogel, Robert A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; FAT INTAKE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VITAMIN METABOLISM;

EID: 0030665744     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.278.20.1682     Document Type: Article

References (54)

1. Connor SL, Gustafson JR, Artaud-Wild SM, et al. The cholesterol/saturated fat index. Lancet. 1986;1: 1229-1232.
2. Vershuren WMM, Jacobs DR, Bloemberg BPM, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. JAMA. 1995;274:131-136.
3. Jha P, Flather M, Lonn E, Farkouh M, Yusuf S. The antioxidant vitamins and cardiovascular disease. Ann Intern Med. 1995;123:860-872.
4. Hegsted DM, McGandy RB, Myers ML, Stare FJ. Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr. 1965;17:281-295.
5. Vogel RA, Corretti MC, Plotnick GD. Effect of a single high-fat meal on endothelial function in healthy subjects. Am J Cordial. 1997;79:350-354.
6. Glasser SP, Selwyn AP, Ganz P. Atherosclerosis: risk factors and the vascular endothelium. Am Heart J. 1996;131:379-384.
7. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC. Coronary vasomotor responses to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81:491-497.
8. Seiler C, Hess M, Buechi M, Suter TM, Krayenbuehl HP. Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries. Circulation. 1993; 88(pt 1):2139-2148.
9. Celermajer DS, Sorensen KE, Bull C, et al. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Call Cardiol. 1994;24:1468-1474.
10. Mano T, Masuyama T, Yamamoto K, et al. Endothelial dysfunction in the early stage precedes appearance of intimal lesions assessable with intravascular ultrasound. Am Heart J. 1996;131:231-238.
11. Reddy KG, Nair RN, Sheehan HM, Hodgson JMcB. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol. 1994;23:833-843.
12. Leung W-H, Lau C-P, Wong C-K. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet. 1993;341:1496-1500.
13. Egashira K, Hirooka Y, Kai H, et al. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation. 1994;89: 2519-2524.
14. Anderson TJ, Meredith IT, Yeung AC. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 1995;332:488-493.
15. Treasure CB, Klein JL, Weintraub WS, et al. Beneficial effects of cholesterol-lowering therapy on the coronary enclothelium in patients with coronary artery disease. N Engl J Med. 1995;332:481-487.
16. Stroes ESG, Koomans HA, de Bruin TWA, Rabelink TJ. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet. 1995;346:467-471.
17. Vogel RA, Corretti MC, Plotnick GP. Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men. Am J Cardiol. 1996;77:37-40.
18. Seiler C, Suter TM, Hess OM. Exercise-induced vasomotion of angiographically normal and stenotic coronary arteries improves after cholesterol-lowering drug therapy with bezafibrate. J Am Coll Cardiol. 1995;26:1615-1622.
19. Ohara Y, Peterson TE, Harrison DG. Hyper-cholesterolemia increases endothelial Superoxide production. J Clin Invest. 1993;91:2546-2551.
20. Shiode N, Nakayama K, Morishima N, Yamagata T, Matsuura H, Kajiyama G. Nitric oxide production by coronary conductance and resistance vessels in hypercholesterolemic patients. Am Heart J. 1996;131:1051-1057.
21. Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF, Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 1996;93:1107-1113.
22. Gilligan DM, Sack MN, Guetta V, et al. Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia. J Am Coll Cardiol. 1994;24:1611-1617.
23. Elliot TG, Barth JD, Mancini GBJ. Effects of vitamin E on endothelial function in men after myocardial infarction. Am J Cardiol. 1995;76:1188-1190.
24. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
25. Corretti MC, Plotnick MC, Vogel RA. Technical aspects of evaluating brachial artery vasodilation using high frequency ultrasound. Am J Physiol. 1995;268H:H1397-H1404.
26. Joannides R, Haefeli WE, Lindner L, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries. Circulation, 1995;91:1314-1319.
27. Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol: modifications of low-density liproprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
28. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med. 1990;323:27-36.
29. Simon BC, Cunningham LD, Cohen RA. Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest. 1990;86:75-79.
30. Anderson TJ, Meredith IT, Charbonneau E. Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. Circulation. 1996;93:1647-1650.
31. Heitzer T, Just H, Munzel T. Antioxidant vitamin C improves endothelial function in chronic smokers. Circulation. 1996;94:6-9.
32. Roberts KA, Rezai AA, Pinkerton KE, Rutledge JC. Effect of environmental tobacco smoke on LDL accumulation in the arterial wall. Circulation. 1996;94:2248-2258.
33. Cayette AJ, Palacino JJ, Cohen RA. Chronic inhibition of nitric oxide production accelerates neointimal formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb. 1994;14:753-759.
34. Hamon M, Vallet B, Bauters C, et al. Long-term administration of L-arginine reduces intimai thickening and enhances neoendotheliam-dependent ace-tylcholine relaxation after arterial injury. Circulation. 1994;90:1357-1362.
35. Jeremy RW, McCarron H, Sullivan D. Effects of dietary L-arginine on atherosclerosis and endothelium-dependent vasodilatation in the hypercholes-terolemic rabbit, Circulation. 1996;94:498-506.
36. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A. 1989;86:6377-6381.
37. Meister A. Glutathione-ascorbic acid antioxidant system in animals. J Biol Chem. 1994;269:9397-9400.
38. Weber C, Erl W, Weber K, Weber PC. Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation. 1996;93:1488-1492.
39. Reilly M, Delanty N, Lawson JA, FitzGerald GA. Modulation of oxidant stress in chronic cigarette smokers. Cirtulation. 1996;94:19-25.
40. Ting HH, Timimi FK, Haley EA, Roddy M-A, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation. 1997;95:2617-2622.
41. Lefroy DC, Crake T, Uren NG, et al. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation. 1993;88:43-54.
42. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444-1449.
43. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328:1450-1456.
44. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med. 1996;334:1156-1162.
45. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;347:781-786.
46. Witzum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest, 1991; 88:1785-1792.
47. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330:1029-1035.
48. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334:1150-1155.
49. Castelli WP. The triglyceride issue: a view from Framingham. Am Heart J. 1986;112:432-437.
50. Austin MA, Goto Y, Lenfant C, Tyroler HA. The hypertriglyceridemias. Am J Cardiol. 1991;68:22A-25A.
51. Slyper AH. A fresh look at the atherogenic remnant hypothesis. Lancet. 1992;340(suppl):289-291.
52. Simpson HS, Williamson CM, Olivecrona T, et al. Postprandial lipemia, fenofibrate and coronary artery disease. Atherosclerosis. 1990;85:193-202.
53. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation. 1979;60:473-485.
54. Vogel RA. Endothelium-dependent vasoregulation of coronary artery diameter and blood flow. Circulation. 1993;88:325-327.